In the healthcare industry, few actions by the federal government caused as much discussion as the 2019 No Surprises Act. When signed into law, this act brought into being several new mechanisms that fundamentally changed the way that providers, payers, and patients deliver, finance, and receive care respectively. None, however, was more impactful than the Independent Dispute Resolution or IDR process.
Designed as a means for payers and providers to seek remediation in the event of a dispute on the price of healthcare, the IDR Process caused heads to turn for a few reasons; not the least of which was at the center of a recent bit of litigation out of Texas on the methodology of the process. However, in late August of 2022, the federal government issued its final rule on the process which has, itself, caused some confusion on its impact and its potential to invite further litigation.
Matthew Albright, Chief Legislative Officer at Zelis, joins this latest episode of the Future Healthcare Today podcast to help sort out the impacts that this final rule has on the immediate future as well as his insights into how this development will shape the course of the IDR process.
To learn more about how the IDR process will affect providers and payers, click here.